Mariagrazia Pizza
Mariagrazia Pizza received her degree in Chemistry and Pharmaceutical Technologies at the University of Naples, Italy. Following a period at the EMBO laboratories in Heidelberg, Germany, Mariagrazia moved to Siena, Italy where she has been ever since, leading many bacterial projects. She has contributed to the discovery of a pertussis vaccine based on a genetically detoxified toxin, able to protect children from disease and to the discovery of new vaccine antigens by genome mining (reverse vaccinology), which are the basis of a new MenB vaccine now licensed in more than 40 countries worldwide. Mariagrazia is currently Senior Scientific Director for Bacterial Vaccines at GSK, and Preclinical Head at GVGH, the GSK Vaccine Institute for Global Health. She has received many scientific awards and is elected member of EMBO, of the European Academy of Microbiology and Academia Europaea, Fellow of the American Academy of Microbiology and Vice President of IUMS (International Union of Microbiology Societies). Mariagrazia is also Honorary Visiting Professor at the University of Leicester and at the Imperial College (UK). She has over 200 publications and is co-inventor of many patents.
Abstracts this author is presenting: